Monitoring of serum nitric oxide in patients with acute leukemia

Iranian Journal of Pharmaceutical Research

Volumn 4, Issue 4, 2005, Pages 233-237

  Ghaffari, Mohammad Ali ^a   Kadkhodaei Elyaderani, Manizheh ^a   Saffari, Mohammad Reza ^b   Pedram, Mohammad ^a  

^a AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b HAMADAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Leukemia; Nitrate; Nitric oxide; Nitrite

Indexed keywords

EID: 79251518545     PISSN: 17350328     EISSN: 17266890     Source Type: Journal    
DOI: 10.22037/IJPR.2010.642     Document Type: Article

References (42)

1. McCall T and Vallance P. Nitric oxide take centre-stage with newly defined roles. Trends Pharmacol. Sci. (1992) 13: 1-6
2. Shmidt HHHW and Walter U. NO at work. Cell (1994) 78: 919-925
3. Brune B, Gotz C, Messmer UK, Sandau K, Hirvonen MR and Lapetina EG. Superoxide formation and macrophage resistance to nitric oxide mediated apoptosis. J. Biol. Chem. (1997) 272: 7253-7258
4. Evance TJ, Buttery LDK, Carpenter A, Springall DR, Polak JM and Cohen J. Cytokine treated human neutrophils contain inducible nitric oxide synthase that produces nitration of ingested bacteria. Proc. Natl. Acad. Sci. U.S.A. (1996) 93: 9553-9558
5. Moncada S. The L-arginine nitric oxide pathway. Acta Physiol. Scand. (1992) 145: 201-227
6. Bredt DS and Snyder SH. Nitric oxide: A physiological messenger molecule. Ann. Rev. Bioch. (1994) 63: 175-195
7. Huang PL and Lo EH. Genetic analysis of NOS isoforms using nNOS and eNOS knockout animals. Prog. Brain Res. (1998) 118: 13-25
8. Stamler JS, Singel Dj and Loscalzo J. Biochemistry of nitric oxide and its redox-activated forms. Science (1992) 258: 1898-1902
9. 450 reductase. Nature (1991) 351: 714-718
10. Clancy MC, Amin AR and Abramson SB. The role of nitric oxide in inflammation and immunity. Arthritis Rheum. (1998) 41: 1141-1151
11. Cho HJ, Xie QW and Calaycay J. Calmodulin as a tightly bound subunit of calcium, calmodulin-independent nitric oxide synthase. J. Exp. Med. (1992) 176: 599-604
12. Hunt NCA and Goldin RD. Nitric oxide production by monocytes in a alcoholic liver disease. J. Hepatol. (1992) 14: 146-150
13. Granger DL, Hibbs JBJr and Perfect JR. Metabolic fate of L-arginine in relation to microbiostatic capability of murine macrophages. J. Clin. Invest. (1990) 85: 264-273
14. Ochoa JB, Udekwu AO and Billiar TR. Nitrogen oxide level in patients after trauma and sepsis. Ann. Surg. (1991) 214: 621-626
15. Hibbs JBJr, Westenfelder C and Tainter R. Evidence for cytokine-inducible nitric oxide synthesis from L-arginine in patients receiving interleukin-2 therapy. J. Clin. Invest. (1992) 89: 867-877
16. Petros A, Bennett D and Vallance P. Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock. Lancet (1991) 338: 1557-1558
17. Middleton SJ, Shorthouse M and Hunter JO. Increased nitric oxide synthesis in ulcerative colitis. Lancet (1993) 341: 465-466
18. McCartney-Francis N, Allen JB and Mizel DE. Suppression of arthritis by an inhibitor of nitric oxide synthesis. J. Exp. Med. (1993) 178: 749-754
19. Parkinson JF, Mitrovic B and Merrill JE. The role of nitric oxide in multiple sclerosis. J. Mol. Med. (1997) 75: 174-186
20. Klob H and Kolb-Bachofen V. Type I (insulin-dependent) diabetes mellitus and nitric oxide. Diabetologia (1992) 35: 796-797
21. Clancy RM and Abramson SB. Nitric oxide: a novel mediator of inflammation. Soc. Exp. Biol. Med. (1995) 210: 93-101
22. Brandao MM, Soares E, Salles TS and Saad ST. Expression of inducible nitric oxide synthase is increased in acute myeloid leukaemia. Acta Haematol. (2001) 106: 95-99
23. Nicholas DJD and Nason A. Determination of nitrate and nitrite. Methods Enzymology (1957) 3: 982-984
24. Gaevara I, Iwanejko J and Dembinska-Kiec A. Determination of nitrite/nitrate in human biological material by the simple Griess-reaction. Clin. Chim. Acta (1998) 274: 177-188
25. Somogyi M. A method for the preparation of blood filtrates for the determination of sugar. J. Biol. Chem. (1930) 86: 655-663
26. Tanner SM, Austin JL and Gustavo L. BAALC, the human member of a novel mammalian neuroectoderm gene lineage, is implicated in hematopoiesis and acute leukemia. Proc. Natl. Acad. Sci. U.S.A. (2001) 98: 13901-13906
27. Dinapoli MR, Calderon CL and Lopez DM. The altered tumoricidal capacity of macrophages isolated from tumor-bearing mice is related to reduce expression of the inducible nitric oxide synthase gene. J. Exp. Med. (1996) 183: 1323-1329
28. Thomsen LL, Lawton FG, Knowles RG, Beesley JE and Moncada S. Nitric oxide synthase activity in human gynecological cancer. Cancer Res. (1994) 54: 1352-1354
29. Thmsen LL, Miles DW, Happerfield L, Bobrow LG, Knowles RG and Monocada S. Nitric oxide synthase activity in human breast cancer. Br. J. Cancer (1995) 72: 41-44
30. Jenkins DC, Charles IG, Thomsen LL and Moss DW. Role of nitric oxide in tumor growth. Proc. Natl. Acad. Sci. U.S.A. (1995) 92: 4392-4396
31. Keating MJ. Chronic lymphocytic leukemia. Semin. Oncol. (1999) 26: 107-114
32. Zhao H, Dugas N, Mathiot C, Delmer A, Dugas B and Sigaux F. B cell chronic lymphocytic leukemia cells express a functional inducible nitric oxide synthase displaying anti apoptotic activity. Blood (1998) 92: 1031-1043
33. Taylor BS and Geller DA. Molecular regulation of the human inducible nitric oxide synthase (iNOS) gene. Shock (2000) 13: 413-424
34. Chartrain NA, Geller DA, Koty PP, Sitrin NF and Nussler AK. Molecular cloning, structure and chromosomal localization of the human inducible nitric oxide synthase gene. J. Biol. Chem. (1994) 269: 6765-6772
35. Levesque MC, Misukonis MA, O'Loughlin CW and Chen Y. IL-4 and interferon gamma regulate expression of inducible nitric oxide synthase in chronic lymphocytic leukemia cells. Leukemia (2003) 17: 442-450
36. Rao KM. Molecular mechanisms regulating iNOS expression in various cell types. J. Toxicol. Environ. Health B Crit. Rev. (2000) 3: 27-58
37. Frank DA, Mahajan S and Ritz J. B lymphocytes from patients with chronic lymphocytic leukemia contain signal transducer and activator of transcription (STAT)1 and STAT3 constitutively phosphorylated on serine residues. J. Clin. Invest. (1997) 100: 3140-3148
38. 23 expression in B-chronic lymphocytic leukemia. Leukemia. Res. (2000) 24: 331-337
39. Mainou-Fowler T, Miller S, Proctor SJ and Dickinson AM. The levels of TNF-alpha, IL-4 and IL-10 Production by T-cells in B-cell chronic lymphocytic leukemia (B-CLL). Leukemia Res. (2001) 25: 157-163
40. Werner ER, Werner-Felmayer G, Fuchs D, Hausen A, Reibnegger G and Yim JJ. Tetrahydrobiopterin biosynthetic activities in human macrophages, fibroblasts, THP-1 and T-24 cells. J. Biol. Chem. (1990) 265: 3189-3192
41. Lim KL, Muir K and Powell RJ. Urine neopterin: A new parameter for serial monitoring of disease activity in patients with systemic lupus erythematosus. Ann. Rheum. Dis. (1994) 53: 743-748
42. Tanaka J, Koshimura K, Tsumori M, Murakami Y and Kato Y. Monitoring of urine nitric oxide related substrates and immunological competence in hematological malignancy. Acta Biochimica Polonica (2002) 49: 227-232